167 related articles for article (PubMed ID: 24650356)
1. Successful Living-Donor Liver Transplant for Fulminant Hepatitis in a Heart Recipient.
Yang PC; Ho CM; Chou NK; Wang SS; Wu YM; Ho MC; Hu RH; Lee PH
Exp Clin Transplant; 2015 Aug; 13(4):369-70. PubMed ID: 24650356
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression and HBV reactivation.
Shouval D; Shibolet O
Semin Liver Dis; 2013 May; 33(2):167-77. PubMed ID: 23749673
[TBL] [Abstract][Full Text] [Related]
3. Retrospective observation of therapeutic effects of adult auxiliary partial living donor liver transplantation on postpartum acute liver failure: a case report.
Li CY; Lai W; Lu SC
World J Gastroenterol; 2015 Mar; 21(9):2840-7. PubMed ID: 25759559
[TBL] [Abstract][Full Text] [Related]
4. Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure.
Bockmann JH; Dandri M; Lüth S; Pannicke N; Lohse AW
World J Gastroenterol; 2015 Feb; 21(7):2214-9. PubMed ID: 25717260
[TBL] [Abstract][Full Text] [Related]
5. A case of cerebral tuberculosis after liver transplant and literature review.
Tunca MZ; Yılmaz Akçay E; Moray G; Özen Ö; Özdemir BH
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():117-9. PubMed ID: 24635807
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B in Solid-Organ Transplant Procedures Other Than Liver.
Halegoua-De Marzio D; Fenkel JM; Doria C
Exp Clin Transplant; 2017 Apr; 15(2):130-137. PubMed ID: 28338458
[TBL] [Abstract][Full Text] [Related]
7. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
8. Successful Management of De Novo Acute Hepatitis B Virus Infection With Entecavir in a Living-Donor Liver Transplant Patient.
Akbulut S; Harputluoglu M; Yilmaz S
Exp Clin Transplant; 2018 Oct; 16(5):635-637. PubMed ID: 29790455
[TBL] [Abstract][Full Text] [Related]
9. Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.
Wong VW; Chan HL
J Gastroenterol Hepatol; 2009 Jul; 24(7):1179-86. PubMed ID: 19682192
[TBL] [Abstract][Full Text] [Related]
10. Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.
Philips CA; Sarin SK
World J Gastroenterol; 2014 Nov; 20(43):16037-52. PubMed ID: 25473156
[TBL] [Abstract][Full Text] [Related]
11. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
[TBL] [Abstract][Full Text] [Related]
12. Acute hepatitis E virus infection causing acute liver failure requiring living-donor liver transplantation in a non-pregnant immunocompetent woman.
Li IWS; Chok KSH
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28295889
[TBL] [Abstract][Full Text] [Related]
13. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
Chen FW; Coyle L; Jones BE; Pattullo V
Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
[TBL] [Abstract][Full Text] [Related]
14. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
[TBL] [Abstract][Full Text] [Related]
16. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
Yaşar DG; Suyanı E; Özenirler S; Sucak GT
Transplant Proc; 2013 Mar; 45(2):833-4. PubMed ID: 23498831
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy decreases viral reactivation in patients with hepatitis B virus-related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial.
Huang L; Li J; Yan J; Sun J; Zhang X; Wu M; Yan Y
J Viral Hepat; 2013 May; 20(5):336-42. PubMed ID: 23565616
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B- and hepatitis D-virus-related liver transplant: single-center data.
Öcal S; Korkmaz M; Harmancı Ö; Ensaroğlu F; Akdur A; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():133-8. PubMed ID: 25894142
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy.
Gonzalez SA; Perrillo RP
Clin Infect Dis; 2016 Jun; 62 Suppl 4(Suppl 4):S306-13. PubMed ID: 27190320
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management.
Xunrong L; Yan AW; Liang R; Lau GK
Rev Med Virol; 2001; 11(5):287-99. PubMed ID: 11590667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
